150 related articles for article (PubMed ID: 31011396)
41. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
Maier LA
Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
[TBL] [Abstract][Full Text] [Related]
42. New aid for diagnosing chronic beryllium disease (CBD): laser ion mass analysis (LIMA).
Williams WJ; Kelland D
J Clin Pathol; 1986 Aug; 39(8):900-1. PubMed ID: 3745481
[TBL] [Abstract][Full Text] [Related]
43. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
44. Cohort mortality study of workers at seven beryllium processing plants: update and associations with cumulative and maximum exposure.
Schubauer-Berigan MK; Couch JR; Petersen MR; Carreón T; Jin Y; Deddens JA
Occup Environ Med; 2011 May; 68(5):345-53. PubMed ID: 20952555
[TBL] [Abstract][Full Text] [Related]
45. Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence.
Boffetta P; Fryzek JP; Mandel JS
Crit Rev Toxicol; 2012 Feb; 42(2):107-18. PubMed ID: 22276590
[TBL] [Abstract][Full Text] [Related]
46. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients.
Müller-Quernheim J; Gaede KI; Fireman E; Zissel G
Eur Respir J; 2006 Jun; 27(6):1190-5. PubMed ID: 16540500
[TBL] [Abstract][Full Text] [Related]
47. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
48. Re: TenHarmsel et al., Mortality Among Individuals Diagnosed With Chronic Beryllium Disease and Beryllium Sensitization.
Boffetta P
J Occup Environ Med; 2024 Jul; 66(7):e323. PubMed ID: 38509655
[No Abstract] [Full Text] [Related]
49. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease.
Fireman E; Haimsky E; Noiderfer M; Priel I; Lerman Y
Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):144-8. PubMed ID: 12870725
[TBL] [Abstract][Full Text] [Related]
50. A model for optimization of biomarker testing frequency to minimize disease and cost: example of beryllium sensitization testing.
Judd NL; Griffith WC; Takaro T; Faustman EM
Risk Anal; 2003 Dec; 23(6):1211-20. PubMed ID: 14641896
[TBL] [Abstract][Full Text] [Related]
51. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
Marchand-Adam S; Guillon F; Brauner M; Valeyre D
Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
[TBL] [Abstract][Full Text] [Related]
52. [Sarcoidosis and berylliosis].
Soriano D; Quartucci C; Agarwal P; Müller-Quernheim J; Frye BC
Internist (Berl); 2022 May; 63(5):557-565. PubMed ID: 35397695
[TBL] [Abstract][Full Text] [Related]
53. [Diagnostic difficulties of chronic pulmonary berylliosis in France].
Ghanem M; Naccache JM; Bonneterre V; L'huillier JP; Guillaud Segard B; Lazor R; Tazi A; Gondouin A; Israël-Biet D; Marquignon MF; Cottin V; Valeyre D; Marchand-Adam S
Rev Mal Respir; 2020 May; 37(5):364-368. PubMed ID: 32279890
[TBL] [Abstract][Full Text] [Related]
54. Long-term efficacy of a program to prevent beryllium disease.
Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
[TBL] [Abstract][Full Text] [Related]
55. Comparison of in vivo and in vitro measures of beryllium sensitization.
Bobka CA; Stewart LA; Engelken GJ; Golitz LE; Newman LS
J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212
[TBL] [Abstract][Full Text] [Related]
56. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.
Snyder JA; Demchuk E; McCanlies EC; Schuler CR; Kreiss K; Andrew ME; Frye BL; Ensey JS; Stanton ML; Weston A
J R Soc Interface; 2008 Jul; 5(24):749-58. PubMed ID: 17956852
[TBL] [Abstract][Full Text] [Related]
57. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
[TBL] [Abstract][Full Text] [Related]
58. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice.
Nikula KJ; Swafford DS; Hoover MD; Tohulka MD; Finch GL
Toxicol Pathol; 1997; 25(1):2-12. PubMed ID: 9061844
[TBL] [Abstract][Full Text] [Related]
59. [Beryllium--underestimated occupational health hazard in Poland].
Dudek W; Walusiak J; Wittczak T
Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
[TBL] [Abstract][Full Text] [Related]
60. Beryllium sensitization and lung function among former workers at the Nevada Test Site.
Rodrigues EG; McClean MD; Weinberg J; Pepper LD
Am J Ind Med; 2008 Jul; 51(7):512-23. PubMed ID: 18459143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
